Work

Figure S4 from PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies

Year: 2023

Type: other

Abstract: PRMT5 inhibitors synergize with PARP inhibition and chemotherapy in breast and ovarian cancer cells in vitro and in vivo.

DOI: 10.1158/2767-9764.24512224

Authors: Jack Carter, Michael Hulse, Monisha Sivakumar, Jessica Burtell, Venkat Thodima, Min Wang, Anjana Agarwal, Komali Vykuntam, Jacob Spruance, Neha Bhagwat, Joseph Rager, Bruce Ruggeri, Peggy Scherle, Koichi Ito

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4388424187

Cites:

Cited by:

Related to: 10